Regeneron Stock Plunges: REGN Tumbles Over 7% in Monday Morning Trading
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is experiencing a significant sell-off in its stock price during Monday morning trading, April 29th. Shares of the biotechnology company have fallen sharply as the market session progresses.
As of 11:54 AM GMT-4, Regeneron stock was trading at 563.57 USD. This represents a substantial decrease of 47.29 USD, translating to a steep 7.74 percent drop compared to the previous closing price of 610.86 USD. The red downward arrow clearly highlights the strong negative momentum impacting the stock today.
The trading day for Regeneron began considerably lower, opening at 561.75 USD. While the stock made a brief attempt to rally, reaching an intraday high of 579.98 USD, intense selling pressure quickly took hold. This drove the shares down significantly to an intraday low of 542.44 USD before finding some support near the 563 USD level.
Regeneron currently possesses a significant market capitalization, listed as 6.16K Cr (representing approximately 61.6 Billion USD). Key financial metrics for the company include a Price-to-Earnings (P/E) ratio of 14.70 and a dividend yield of 0.62 percent.
Today’s sharp decline pushes REGN stock significantly lower within its 52-week trading range. The highest price the shares have reached over the past year stands at 1,211.20 USD, while the lowest point recorded during that period was 525.99 USD, a level the stock approached during today’s session.
